You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,150,398


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,150,398
Title: Methods for the treatment of cancer
Abstract:A pharmaceutical composition comprising an effective cancerous cell growth inhibiting amount of paclitaxel, or a paclitaxel derivative, and an effective cancerous cell growth inhibiting amount of an active agent which inhibits cancerous cell growth by exerting an effect on mammalian cell cycle during G.sub.1 or S-phase of the cell division cycle to inhibit said cancerous cell growth and methods of using same.
Inventor(s): Vande Woude; George F. (Berryville, VA), Schulz; Nicholas (Pittsburgh, PA), Zhou; Renping (Frederick, MD), Daar; Ira (Frederick, MD), Oskarsson; Marianne (Gaitherburg, MD)
Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC)
Application Number:08/618,863
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,150,398

Introduction

Patent 6,150,398, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. To analyze this patent, we need to delve into its various components, including the background, summary, detailed description, and most importantly, the claims.

Background of the Patent

Before diving into the specifics of Patent 6,150,398, it is crucial to understand the context in which it was filed. This includes the state of the art at the time of the invention, any prior art that may have influenced the invention, and the problems the invention aimed to solve.

Summary of the Invention

The summary section provides a brief overview of the invention. This section is essential for understanding the core concept and the main features of the invention. For Patent 6,150,398, the summary would typically outline the key aspects of the invention, such as its purpose, its novel features, and how it differs from existing solutions.

Detailed Description of the Invention

This section provides a detailed explanation of the invention, including drawings, diagrams, and a thorough description of how the invention works. It is here that the inventor explains the various components, their interactions, and the methods or processes involved in the invention.

Claims of the Patent

The claims are the most critical part of a patent as they define the scope of protection. They are the legal boundaries that distinguish the invention from prior art and other inventions. Here are some key points to consider when analyzing the claims of Patent 6,150,398:

Independent and Dependent Claims

  • Independent claims stand alone and define the invention without reference to other claims. They are the broadest claims and set the outer limits of the patent's protection.
  • Dependent claims, on the other hand, refer back to an independent claim and further limit the scope of the invention. They often add additional features or details to the independent claims[2].

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is crucial for determining the scope of protection and for infringement analysis. The claims must be clear and definite to avoid ambiguity and ensure that the patent is enforceable[2].

Claim Types

  • Method Claims: These claims cover a process or method of performing an action.
  • Apparatus Claims: These claims cover a physical device or system.
  • Composition of Matter Claims: These claims cover a new chemical compound or material.
  • Product-by-Process Claims: These claims cover a product that is defined by the process used to make it.

Scope of Protection

The scope of protection is defined by the claims and is a critical aspect of patent analysis. It determines what is protected and what is not. Here are some key considerations:

Novelty and Non-Obviousness

For a patent to be valid, the invention must be novel and non-obvious. This means that the invention must be new and not obvious to a person with ordinary skill in the relevant field. The claims must reflect this novelty and non-obviousness to ensure that the patent is enforceable[2].

Enablement and Written Description

The patent application must include a detailed description that enables a person with ordinary skill in the art to make and use the invention without undue experimentation. The claims must also be supported by the written description to ensure that the scope of protection is justified[2].

Patent Landscape

Understanding the patent landscape involves analyzing the broader context in which the patent exists. This includes:

Prior Art

Prior art refers to any publicly available information that existed before the filing date of the patent. Analyzing prior art helps in understanding how the invention differs from what was already known and whether the claims are valid[2].

Related Patents

Looking at related patents, especially those in the same family or those that claim priority from the same application, can provide insights into the evolution of the technology and potential issues like obviousness-type double patenting (ODP)[1].

Patent Term and Adjustments

The patent term and any adjustments, such as Patent Term Adjustment (PTA) for USPTO delays, can affect when the patent expires. This is crucial for understanding the duration of protection and any potential extensions[1].

Economic and Practical Considerations

The economic and practical implications of the patent are also important:

Commercial Viability

The commercial viability of the invention is a key factor. If the invention is not commercially valuable, it may not be worth the cost of obtaining and maintaining the patent. The costs of drafting, filing, and prosecuting a patent can be significant, ranging from $8,000 to $20,000 for a U.S. non-provisional patent application, and even higher for international patents[2].

Enforcement and Litigation

The enforceability of the patent is another critical aspect. If the claims are too broad or ambiguous, they may be difficult to enforce, leading to potential litigation issues. The cost and complexity of patent litigation can be substantial, making it essential to ensure that the claims are clear and well-supported[5].

Case Studies and Legal Precedents

Analyzing case studies and legal precedents related to similar patents can provide valuable insights:

Obviousness-Type Double Patenting (ODP)

For example, the case of In re Cellect LLC highlights the importance of ODP analysis, especially in cases where multiple patents in the same family are involved. This case shows how ODP can invalidate claims if they are not properly distinguished from earlier patents in the same family[1].

Patent Term Extensions

Another example is the Novartis AG v. Ezra Ventures LLC case, which clarifies that ODP does not invalidate a validly obtained Patent Term Extension (PTE) under 35 U.S.C. ยง 156. This is important for understanding how patent term adjustments and extensions can impact the overall protection period[1].

Key Takeaways

  • Claims Definition: The claims are the heart of a patent and define the scope of protection.
  • Novelty and Non-Obviousness: The invention must be new and not obvious to a person with ordinary skill in the relevant field.
  • Enablement and Written Description: The patent application must include a detailed description that enables a person with ordinary skill in the art to make and use the invention.
  • Patent Landscape: Understanding prior art, related patents, and the broader patent landscape is crucial for validating the claims.
  • Economic Considerations: The commercial viability and enforcement costs of the patent are important factors in determining its value.

FAQs

Q: What is the primary purpose of the claims in a patent? A: The primary purpose of the claims in a patent is to define the scope of protection for the invention.

Q: How does obviousness-type double patenting (ODP) affect patents? A: ODP can invalidate claims if they are not properly distinguished from earlier patents in the same family, ensuring that each patent in a family does not claim the same invention.

Q: What is the significance of the written description in a patent application? A: The written description must enable a person with ordinary skill in the art to make and use the invention without undue experimentation and must support the claims.

Q: How do patent term adjustments affect the duration of patent protection? A: Patent term adjustments, such as those for USPTO delays, can extend the patent term, ensuring that the inventor receives the full term of protection despite delays in the prosecution process.

Q: Why is commercial viability important for a patent? A: Commercial viability is crucial because the costs of obtaining and maintaining a patent are significant, and if the invention is not commercially valuable, it may not be worth the investment.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,150,398

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,150,398

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2005692 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 9219765 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.